Karolinska Development - Q4 and 2016 Year-End Report - invitation to conference call and webcast
(Thomson Reuters ONE) -
STOCKHOLM - FEBRUARY 22, 2017. Karolinska Development AB (Nasdaq Stockholm:
KDEV) will publish its Q4 and 2016 Year-End Report on February 28, 2017. The
company will also host a conference call and an online presentation on the same
day at 14.00 CET.
Please dial in at one of the following numbers a few minutes before the start of
the conference call:
* From Sweden: +46 (0) 8 505 564 74
* From the US: +1 855 753 22 30
* From the UK: +44 (0) 20 336 453 74
The presentation will also be webcast and can be accessed from the following web
address:
http://edge.media-server.com/m/p/bzmwoimv
Host: Jim Van heusden, CEO.
For further information, please contact:
Jim Van heusden, CEO, Karolinska Development AB
Phone: +46 72 858 32 09, e-mail: jim.van.heusden(at)karolinskadevelopment.com
Christian Tange, CFO, Karolinska Development AB
Phone: +46 73 712 14 30, e-mail: christian.tange(at)karolinskadevelopment.com
David Dible/Mark Swallow/Pip Batty, Citigate Dewe Rogerson
Phone: +44 20 7638 9571; e-mail: KDev(at)citigatedr.co.uk
TO THE EDITORS
About Karolinska Development AB
Karolinska Development AB is an investment company focused on identifying
medical innovation and investing in the creation and growth of companies
developing these assets into differentiated products that will make a difference
to patients' lives and provide an attractive return on investment.
Karolinska Development has access to world-class medical innovations at the
Karolinska Institutet and other leading universities and research institutes in
the Nordic region. The Company aims to build companies around scientists who are
leaders in their fields, supported by experienced management teams and advisers,
and co-funded by specialist international investors, to provide the greatest
chance of success.
Karolinska Development has established a portfolio of nine companies targeting
opportunities in innovative treatment for life-threatening or serious
debilitating diseases.
The Company is led by a team including investment professionals with strong
venture capital backgrounds, experienced company builders and entrepreneurs,
with access to a strong global network.
For more information, please visit www.karolinskadevelopment.com
This information is information that Karolinska Development AB (publ) (Nasdaq
Stockholm: KDEV) is obliged to make public pursuant to the EU Market Abuse
Regulation and the Securities Markets Act. The information was submitted for
publication, through the agency of Jim Van heusden, at 2 pm CET on 22 February
2017.
Karolinska Development Q4 2016 Invitation PR (ENG):
http://hugin.info/143071/R/2081019/783711.pdf
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Karolinska Development AB (publ) via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 22.02.2017 - 14:00 Uhr
Sprache: Deutsch
News-ID 525824
Anzahl Zeichen: 3476
contact information:
Town:
Solna
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 203 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Karolinska Development - Q4 and 2016 Year-End Report - invitation to conference call and webcast"
steht unter der journalistisch-redaktionellen Verantwortung von
Karolinska Development AB (publ) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
